Trial Profile
Targeting Glial Inhibition to Attenuate Chronic Migraine: AN INTERNATIONAL DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL OF IBUDILAST
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ibudilast (Primary)
- Indications Migraine
- Focus Adverse reactions; Therapeutic Use
- 28 Dec 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov
- 24 Jun 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 25 Feb 2013 Planned initiation date changed from 1 Sep 2011 to 1 Jun 2013 as reported by ClinicalTrials.gov record.